These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38316873)
1. Efficacy evaluation of a bivalent subunit vaccine against classical swine fever virus and porcine circovirus type 2. Chen YS; Lee CY; Wu CC; Kao PL; Chen TA; Huang Y; Chung WB; Kuo TY; Chen C Sci Rep; 2024 Feb; 14(1):2997. PubMed ID: 38316873 [TBL] [Abstract][Full Text] [Related]
2. A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission. Chen JY; Wu CM; Chia MY; Huang C; Chien MS Vet Res; 2023 Jul; 54(1):57. PubMed ID: 37434231 [TBL] [Abstract][Full Text] [Related]
3. The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications. Chen JY; Wu CM; Liao CM; Chen KC; You CC; Wang YW; Huang C; Chien MS Vaccine; 2019 Oct; 37(43):6535-6542. PubMed ID: 31500966 [TBL] [Abstract][Full Text] [Related]
4. Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine. Huang YL; Pang VF; Lin CM; Tsai YC; Chia MY; Deng MC; Chang CY; Jeng CR Vet Res; 2011 Dec; 42(1):115. PubMed ID: 22129109 [TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus. Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579 [TBL] [Abstract][Full Text] [Related]
6. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model. Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266 [TBL] [Abstract][Full Text] [Related]
7. Impact of porcine reproductive and respiratory syndrome virus and porcine circovirus-2 infection on the potency of the classical swine fever vaccine (LOM strain). Lim SI; Jeoung HY; Kim B; Song JY; Kim J; Kim HY; Cho IS; Woo GH; Lee JB; An DJ Vet Microbiol; 2016 Sep; 193():36-41. PubMed ID: 27599928 [TBL] [Abstract][Full Text] [Related]
8. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets. Zhang H; Qian P; Peng B; Shi L; Chen H; Li X Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115 [TBL] [Abstract][Full Text] [Related]
9. A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protect Pigs against a Virulent CSFV Challenge. Silva E; Medina-Ramirez E; Pavulraj S; Gladue DP; Borca M; Chowdhury SI Viruses; 2023 Oct; 15(11):. PubMed ID: 38005821 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of bivalent vaccines of porcine circovirus type 2 and Lim J; Jin M; Yoon I; Yoo HS J Vet Sci; 2022 May; 23(3):e49. PubMed ID: 35618321 [TBL] [Abstract][Full Text] [Related]
11. Secreted Expression of the Cap Gene of Porcine Circovirus Type 2 in Classical Swine Fever Virus C-Strain: Potential of C-Strain Used as a Vaccine Vector. Zhang L; Li Y; Xie L; Wang X; Gao X; Sun Y; Qiu HJ Viruses; 2017 Oct; 9(10):. PubMed ID: 29035292 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions. Park C; Jeong J; Choi K; Chae C Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis. Li PC; Qiao XW; Zheng QS; Hou JB Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858 [TBL] [Abstract][Full Text] [Related]
14. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and Yang S; Park SJ; Oh T; Cho H; Chae C Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976 [TBL] [Abstract][Full Text] [Related]
15. Porcine circovirus type 2 decreases the infection and replication of attenuated classical swine fever virus in porcine alveolar macrophages. Huang YL; Pang VF; Deng MC; Chang CY; Jeng CR Res Vet Sci; 2014 Feb; 96(1):187-95. PubMed ID: 24370262 [TBL] [Abstract][Full Text] [Related]
16. [Generation and characterization of recombinant classical swine fever virus C-strain expressing the cap protein of porcine circovirus type 2]. Zhang L; Li Y; Xie L; Sun Y; Wang X; Qiu HJ Sheng Wu Gong Cheng Xue Bao; 2018 Feb; 34(2):216-223. PubMed ID: 29424135 [TBL] [Abstract][Full Text] [Related]
17. Efficacy in pigs of a new inactivated vaccine combining porcine circovirus type 2 and Mycoplasma hyorhinis. Wei YW; Zhu HZ; Huang LP; Xia DL; Wu HL; Bian HQ; Feng L; Liu CM Vet Microbiol; 2020 Mar; 242():108588. PubMed ID: 32122592 [TBL] [Abstract][Full Text] [Related]
18. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge. Oh Y; Seo HW; Park C; Chae C Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364 [TBL] [Abstract][Full Text] [Related]
19. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2. Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge. Park KH; Oh T; Yang S; Cho H; Kang I; Chae C Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]